India's indigenous CRISPR-based gene-editing therapy for sickle cell disease: innovation to equitable implementation

The Lancet Regional Health - Southeast Asia · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles